EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Angiopoietin‐like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients

Yan Wang, Kun Li, Shasha Yuan, Caiguo Yu, Ruili Yin, Di Wang, Yongsong Xu, Lijie Zhang, Lingling Wei, Yanan Cheng, Lin Mao, Dong Zhao iD und 1 weitere

Journal of Diabetes Investigation · 2024

DOI: 10.1111/jdi.14304 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Investigation, 2024. Verfasst von Yan Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Diabetes Prevention and Research, Center for Endocrine Metabolic and Immune Diseases, Beijing Luhe Hospital, Capital Medica…. Hauptthemen laut MEDLINE: Angiopoietin-Like Protein 4, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Biomarkers. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Municipal Commission of Education, Beijing Municipal Education Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/Introduction The association between serum angiopoietin‐like 4 (ANGPTL4) levels and the severity of diabetic kidney disease (DKD) in patients with type 2 diabetes mellitus remains unclear.

Methods

A total of 1,115 type 2 diabetes mellitus patients were analyzed in this cross‐sectional study. DKD index included DKD stages defined by estimated glomerular filtration rate, the albuminuria grades and DKD risk management grades. Serum levels of ANGPTL4 and other biomarkers were detected. Multivariable‐adjusted linear and logistic analyses were used to study the association between ANGPTL4 and DKD. The protein levels of ANGPTL4 were assessed in the kidney. Renal tubular cells were stimulated with glucose to study ANGPTL4 expression.

Results

Compared with the participants in the third or fourth quantile of ANGPTL4, those in the first or second quantile of ANGPTL4 were younger, with lower glycated hemoglobin, triglycerides and urinary albumin creatinine ratio (all P < 0.05). There was a negative nonlinear relationship between ANGPTL4 and estimated glomerular filtration rate in type 2 diabetes mellitus patients. One standard deviation increased serum ANGPTL4 levels, the odds ratio of having DKD was 1.40 (95% confidence interval 1.08–1.80). The mediation analysis showed that triglycerides did not mediate the association between ANGPTL4 and DKD. Furthermore, ANGPTL4 could be the strongest among multiple panels of biomarkers in its association of DKD. Compared with mice at 8 weeks‐of‐age, db / db mice at 18 weeks‐of‐age had increased ANGPTL4 expression in glomeruli and tubular segments. In vitro , glucose could stimulate ANGPTL4 expression in tubular cells in a dose‐dependent manner.

Conclusions

ANGPTL4 could be a potential marker and therapeutic target for DKD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiopoietin-Like Protein 4Diabetes Mellitus, Type 2Diabetic NephropathiesBiomarkersHumansMaleFemaleMiddle AgedCross-Sectional StudiesMiceAnimalsGlomerular Filtration RateAged

Stichwörter der Autor:innen

Angiopoietin‐like 4Diabetic kidney diseaseEstimated glomerular filtration rate

Substanzen

Angiopoietin-Like Protein 4BiomarkersANGPTL4 protein, human

Autor:innen und Institutionen

  • Beijing Key Laboratory of Diabetes Prevention and Research, Center for Endocrine Metabolic and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: Dong Zhao, Longyan Yang

Förderung

  • National Natural Science Foundation of China
  • Beijing Municipal Commission of Education
  • Beijing Municipal Education Commission

Zitieren

APA

Wang, Y., Li, K., Yuan, S., Yu, C., Yin, R., Wang, D., Xu, Y., Zhang, L., Wei, L., Cheng, Y., Mao, L., Zhao, D., & Yang, L. (2024). Angiopoietin‐like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.14304

Vancouver

Wang Y, Li K, Yuan S, Yu C, Yin R, Wang D, et al. Angiopoietin‐like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients. Journal of Diabetes Investigation. 2024. doi:10.1111/jdi.14304

BibTeX
@article{Wang2024,
  author = {Wang, Yan and Li, Kun and Yuan, Shasha and Yu, Caiguo and Yin, Ruili and Wang, Di and Xu, Yongsong and Zhang, Lijie and Wei, Lingling and Cheng, Yanan and Mao, Lin and Zhao, Dong and Yang, Longyan},
  title = {Angiopoietin‐like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients},
  journal = {Journal of Diabetes Investigation},
  year = {2024},
  doi = {10.1111/jdi.14304}
}
Kostenlos starten →